Seagen is a biotechnology company specializing in antibody-drug conjugates (ADCs) for treating cancer. Pfizer completed its acquisition of Seagen in 2023.
We dig behind Pfizer-Seagen's stated narrative to unravel the real strategy — the calls that actually shaped it, and why they played out the way they did.
Growth & Portfolio
Company profile
Industry
Biotechnology
Headquarters
Bothell, United States
Ownership
Acquired by Pfizer in 2023
Profiles are auto-generated and infrequently updated.